From the United States to Australia, from Germany to Colombia, the Canadian cannabis sector continues to capitalize on an emerging global industry.

As countries around the world continue to reform their laws and legalize medical marijuana, new opportunities are created for Canadian cannabis producers.

Colombia Cannabis Industry Heats Up

Earlier this week, ICC International Cannabis Corporation (ICC.V) (ICCLF) announced that it has incorporated a subsidiary in Colombia, ICC Colombia S.A.S. to apply for a series of licenses pursuant to Article 2.8.11.2.1.2 of the Decree 613 of 2017, Article that develops Law1787 of 2016:

• Seed License: This license grants a permit for the management of seeds that can be imported, exported, stored, transported and commercialized within Colombia.
• Non-psychoactive Cannabis Cultivation License: This license grants a permit to grow non-psychoactive cannabis plants, including seeding, purchase and production of seeds, sale, distribution, export and use for scientific purposes.
• Psychoactive Cannabis Cultivation License: This license grants a permit to grow psychoactive cannabis plants, including seeding, purchase and production of seeds, sale, distribution, export and use for scientific purposes.
• Manufacturing License: This license grants a permit for the formulation and manipulation of cannabis by-products. These can be imported, exported, stored, transported and marketed.

According to the latest news released by the Colombian Government, regulations are expected to be ready in the second half of 2017. This move is part of ICC’s strategy to become the world's largest and lowest cost producers of CBD. The new subsidiary combined with ICC’s track record leave the company confident in their opportunity. ICC expects to enter new jurisdictions in the coming months.

Canopy: A Global Growth Opportunity

Canopy Growth Corp. (WEED.TO) (TWMJF) has evolved from being the largest licensed medical cannabis producer in Canada into the largest licensed producer in the world. The company sells cannabis on three continents and it continues to increase its market share by making strategic investments all over the world.

In late 2016, Canopy Growth reported an agreement to acquire MedCann GmbH Pharma and Nutraceuticals, a German-based pharmaceutical distributor that has placed Tweed-branded cannabis strains in German pharmacies. MedCann is federally licensed by the German Health Ministry to import, manufacture and distribute medical cannabis products.

Canopy Growth has also entered the Australian medical cannabis industry through a partnership with AussCann (ACNNF). Canopy will help AussCann increase market share and capitalize on the Australian cannabis market. Canopy is not only one of AussCann’s largest shareholders but they have also granted them royalty-free access to their intellectual property as it relates to cultivation, supply, and manufacturing of medicinal cannabis.

Canadian Producer Plants Flag in Florida

In April, Aphria Inc. (APH.TO) (APHQF) announced the launch of its United States expansion strategy through a lead investment in Liberty Health Sciences which will operate under Aphria USA.

Read the rest of the article